ResearcherFirst Hospital of Jilin UniversityActive in the last 2 years

Nan Qin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5100308537. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

Distinct safety profiles of albumin-bound nab-paclitaxel and paclitaxel in pancreatic cancer focusing on hematologic and hepatobiliary risks. Co-author DOI 10.1038/s41598-025-16848-y ↗
Trends in pancreatic cancer mortality among US adults, 1999-2023. Co-author DOI 10.1186/s12876-025-04354-4 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jingtao Chen · 1 shared paper, 2025 · strength 0.42
- Paper Distinct safety profiles of albumin-bound nab-paclitaxel and paclitaxel in pancreatic cancer focusing on hematologic an… DOI 10.1038/s41598-025-16848-y ↗
Tianxing Wu · 1 shared paper, 2025 · strength 0.37
- Paper Trends in pancreatic cancer mortality among US adults, 1999-2023. DOI 10.1186/s12876-025-04354-4 ↗
Jingtao Chen · 1 shared paper, 2025 · strength 0.37
- Paper Trends in pancreatic cancer mortality among US adults, 1999-2023. DOI 10.1186/s12876-025-04354-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.